U.S. Markets closed

Celgene Corporation (CELG)


NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
137.74+1.43 (+1.05%)
At close: 4:00PM EDT
People also watch
GILDBIIBREGNAMGNALXN
Full screen
Previous Close136.31
Open136.23
Bid137.86 x 100
Ask138.37 x 100
Day's Range135.72 - 138.17
52 Week Range96.93 - 138.17
Volume3,651,611
Avg. Volume3,952,476
Market Cap107.55B
Beta1.47
PE Ratio (TTM)51.72
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Biotechs On A Hot Streak, And Could Be 'Cooking With Gas'
    Investor's Business Daily8 hours ago

    Biotechs On A Hot Streak, And Could Be 'Cooking With Gas'

    IBD's 439-company Biotech industry group is now ranked fourth out of 197. How far can the rally go?

  • Barrons.com9 hours ago

    Nothing Can Keep Celgene Down

    When it comes to Celgene (CELG), what goes might must keep going up. Shares of Celgene started rallying on June 1, and after taking a break through the first couple of weeks of July, its shares are on the move again. In fact Celgene is trading a new 52-week high today.

  • Barrons.com11 hours ago

    Will Gilead Beat 2Q Earnings? Perhaps…But Does It Matter?

    Is Gilead Sciences (GILD) poised for a beat next week? Guggenheim analyst Tony Butler sees Gilead earning $2.15 a share, a penny above the consensus forecast compiled by sell-side analyst, with operating revenue of $6.54 billion beating the $6.31 billion expected by the Street. Butler’s estimates for the full 2017 calendar year are also above consensus, with per-share earnings of $8.28 on operating revenue of $25.4 billion.